Literature DB >> 16397528

Locus-specific mutation databases: pitfalls and good practice based on the p53 experience.

Thierry Soussi1, Chikashi Ishioka, Mireille Claustres, Christophe Béroud.   

Abstract

Between 50,000 and 60,000 mutations have been described in various genes that are associated with a wide variety of diseases. Reporting, storing and analysing these data is an important challenge as such data provide invaluable information for both clinical medicine and basic science. Locus-specific databases have been developed to exploit this huge volume of data. The p53 mutation database is a paradigm, as it constitutes the largest collection of somatic mutations (22,000). However, there are several biases in this database that can lead to serious erroneous interpretations. We describe several rules for mutation database management that could benefit the entire scientific community.

Entities:  

Mesh:

Year:  2006        PMID: 16397528     DOI: 10.1038/nrc1783

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  59 in total

Review 1.  Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases.

Authors:  Shuk-mei Ho; Wan-yee Tang
Journal:  Reprod Toxicol       Date:  2007-01-19       Impact factor: 3.143

Review 2.  Epigenetic reprogramming and imprinting in origins of disease.

Authors:  Wan-yee Tang; Shuk-mei Ho
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

3.  The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis.

Authors:  Siddharth Singh; Manoj Kumar; Sanjeev Kumar; Shrinka Sen; Pawan Upadhyay; Sayan Bhattacharjee; Naveen M; Vivek Singh Tomar; Siddhartha Roy; Amit Dutt; Tapas K Kundu
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

4.  p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression.

Authors:  Sachiyo Okayama; Levy Kopelovich; Gabriel Balmus; Robert S Weiss; Brittney-Shea Herbert; Andrew J Dannenberg; Kotha Subbaramaiah
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

5.  Inhibition of p53 DNA binding function by the MDM2 protein acidic domain.

Authors:  Brittany Cross; Lihong Chen; Qian Cheng; Baozong Li; Zhi-Min Yuan; Jiandong Chen
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

6.  Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.

Authors:  Wooin Lee; Abbes Belkhiri; A Craig Lockhart; Nipun Merchant; Hartmut Glaeser; Elizabeth I Harris; M Kay Washington; Elizabeth M Brunt; Alex Zaika; Richard B Kim; Wael El-Rifai
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

7.  p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.

Authors:  Christian J Braun; Xin Zhang; Irina Savelyeva; Sonja Wolff; Ute M Moll; Troels Schepeler; Torben F Ørntoft; Claus L Andersen; Matthias Dobbelstein
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes.

Authors:  Marc S Greenblatt; Lawrence C Brody; William D Foulkes; Maurizio Genuardi; Robert M W Hofstra; Magali Olivier; Sharon E Plon; Rolf H Sijmons; Olga Sinilnikova; Amanda B Spurdle
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

9.  Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2.

Authors:  Yoshinori Abe; Eri Oda-Sato; Kei Tobiume; Keiko Kawauchi; Yoichi Taya; Koji Okamoto; Moshe Oren; Nobuyuki Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-21       Impact factor: 11.205

10.  The p53 core domain is a molten globule at low pH: functional implications of a partially unfolded structure.

Authors:  Ana Paula D Ano Bom; Monica S Freitas; Flavia S Moreira; Danielly Ferraz; Daniel Sanches; Andre M O Gomes; Ana Paula Valente; Yraima Cordeiro; Jerson L Silva
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.